Bioceltix S.A. (WSE:BCX)
Poland flag Poland · Delayed Price · Currency is PLN
69.00
+0.70 (1.02%)
Nov 4, 2026, 3:56 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
382382431372133172
Market Cap Growth
-20.09%-11.42%16.07%179.48%-22.49%-
Enterprise Value
325359394357130-
Last Close Price
68.3077.6087.6090.0038.8052.20

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
6.115.2211.1235.5125.8228.60
P/TBV Ratio
6.115.2211.1235.5125.8228.60

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.020.020.060.09
Net Debt / Equity Ratio
-0.91-0.93-0.85-0.87-0.74-0.92
Net Debt / EBITDA Ratio
3.164.702.320.670.451.37
Net Debt / FCF Ratio
2.544.891.840.600.471.37
Inventory Turnover
--126.03---
Quick Ratio
19.2632.4918.665.231.943.41
Current Ratio
19.3032.5118.695.242.683.42
Return on Equity (ROE)
-39.45%-27.06%-59.03%-175.28%-160.02%-94.35%
Return on Assets (ROA)
-22.94%-16.23%-34.19%-85.92%-70.62%-42.35%
Return on Capital Employed (ROCE)
-29.70%-20.60%-37.70%-132.30%-165.70%-70.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-5.06%-3.97%-3.37%-3.68%-6.71%-2.56%
FCF Yield
-5.84%-3.64%-4.13%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-7.61%-10.18%-15.76%-17.48%-5.54%-